Axogen, Inc.
AXGNdata completeness 100%16 fiscal years on fileAxogen, Inc. earns about -19% on equity, but has diluted owners by 12% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $127.4M1 | $138.6M2 | $159M3 | $187.3M3 | $225.2M3 |
| Net income | −$27M4 | −$28.9M5 | −$21.7M6 | −$9.96M6 | −$15.7M6 |
| Operating cash flow | −$13.4M7 | −$16.1M8 | −$5.72M9 | $4.54M9 | $812,0009 |
| Capital expenditure | $27.8M10 | $20.1M11 | $13.9M12 | $3.1M12 | $3.75M12 |
| Free cash flow (derived) | −$41.2M7 | −$36.1M8 | −$19.6M9 | $1.43M9 | −$2.93M9 |
| Total debt | $89.6M13 | $91.4M14 | $93.2M15 | $95M16 | $96.8M16 |
| Cash & equivalents | $32.8M17 | $15.3M18 | $31M19 | $27.6M20 | $35.5M20 |
| Diluted shares | 41.2M | 42.1M | 42.9M | 44.3M | 46.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $27.98 of net worth that earned you −$3.41 and generated −$0.64 of cash last year, against $21.01 of debt.
It earned an average -19% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 12% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0000805928-24-000028 (Revenues)
- 10-K · period ending 2022-12-31 · accession 0000805928-25-000017 (Revenues)
- 10-K · period ending 2023-12-31 · accession 0000805928-26-000031 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0000805928-24-000028 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000805928-25-000017 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0000805928-26-000031 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0000805928-24-000028 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000805928-25-000017 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0000805928-26-000031 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0000805928-24-000028 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0000805928-25-000017 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0000805928-26-000031 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0000805928-23-000020 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0000805928-24-000028 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0000805928-25-000017 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0000805928-26-000031 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0000805928-23-000020 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0000805928-24-000028 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0000805928-25-000017 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0000805928-26-000031 (CashAndCashEquivalentsAtCarryingValue)